China approves CSPC Pharma mRNA cancer therapy for clinical trials
SHANGHAI, June 26 (Reuters) - A cancer cell therapy from CSPC Pharmaceutical Group that uses synthetic messenger RNA (mRNA) technology has received regulatory clearance in China for human clinical trial, the Chinese drugmaker said late on Tuesday. CSPC and …